Soros Fund Management - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 4 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$2,963,0002,000,0000.15%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AQR Arbitrage LLC 4,225,000$3,897,5630.18%
WOLVERINE ASSET MANAGEMENT LLC 5,690,000$5,247,8640.06%
D. E. Shaw & Co., Inc. 6,500,000$6,049,2250.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders